Cancer Clinical Trial -HonorHealth Research Institute-HRI-Lurbinectedin-001

Status:

Open

ClinicalTrials.gov:

NCT05229588

Lurbinectedin in Patients With Advanced Pancreatic Cancer With DNA Repair Mutations

Drug

Lurbinectedin

Phase

Phase II

Condition

Pancreatic

Keywords

DNA Repair Mutations